Symptoms and lung function decline in a middle-aged cohort of males and females in Australia

International Journal of COPD

Volumn 11, Issue 1, 2016, Pages 1097-1103

  Abramson, Michael J ^a   Kaushik, Sonia ^a   Benke, Geza P ^a   Borg, Brigitte M ^b   Smith, Catherine L ^a   Dharmage, Shyamali C ^c   Thompson, Bruce R ^b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Body mass index; Cohort study; COPD; Lung function; Respiratory symptoms; Tobacco smoking

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; BODY MASS; COHORT ANALYSIS; DETERIORATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION DECLINE; MALE; MATERNAL SMOKING; MIDDLE AGED; OBESITY; SEX DIFFERENCE; SMOKING; SPIROMETRY; WHEEZING; ADVERSE EFFECTS; ASTHMA; BODY HEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH DISPARITY; HEALTH STATUS; LUNG; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; VICTORIA; VITAL CAPACITY;

ADULT; AGE FACTORS; ASTHMA; BODY HEIGHT; BODY MASS INDEX; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEALTH STATUS DISPARITIES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUNG; MALE; OBESITY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; SMOKING; TIME FACTORS; VICTORIA; VITAL CAPACITY;

EID: 84970046732     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S103817     Document Type: Article

References (36)

1. Burney P, Chinn DJ, Luczynska C, Lai E. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey. Eur Respir J. 1996;9:687–695.
2. Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1997;99(3):314–322.
3. Abramson M, Kutin JJ, Raven J, Lanigan A, Czarny D, Walters EH. Risk factors for asthma among young adults in Melbourne, Australia. Respirology. 1996;1(4):291–297.
4. de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175(1):32–39.
5. Karunanayake CP, Rennie DC, Pahwa P, Chen Y, Dosman JA. Predictors of respiratory symptoms in a rural Canadian population: A longitudinal study of respiratory health. Can Respir J. 2011;18(3):149–153.
6. James AL, Knuiman MW, Divitini ML, et al. Risk factors for respiratory symptoms in adults: the Busselton Health Study. Respirology. 2013;18(8):1256–1260.
7. Skorge TD, Eagan TM, Eide GE, Gulsvik A, Bakke PS. The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. Am J Respir Crit Care Med. 2005;172(1):61–66.
8. Jacquemin B, Siroux V, Sanchez M, et al. Ambient air pollution and adult asthma incidence in six European cohorts (ESCAPE). Environ Health Perspect. 2015;123(6):613–621.
9. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187.
10. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008;177(3):253–260.
11. Fletcher C, Peto R, Tinker C, Speizer F. The Natural History of Chronic Bronchitis and Emphysema. Oxford: Oxford University Press; 1976: 78–85, Appendix B:163–223.
12. Wilken D, Velasco Garrido M, Manuwald U, Baur X. Lung function in asbestos-exposed workers, a systematic review and meta-analysis. J Occup Med Toxicol. 2011;6(1):21.
13. Portengen L, Hollander A, Doekes G, de Meer G, Heederik D. Lung function decline in laboratory animal workers: the role of sensitisation and exposure. Occup Environ Med. 2003;60(11):870–875.
14. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339(17):1194–1200.
15. Tai A, Tran H, Roberts M, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol. 2014;133(6):1572–1578.
16. Frew AJ, Kennedy SM, Chan-Yeung M. Methacholine responsiveness, smoking, and atopy as risk factors for accelerated FEV1 decline in male working populations. Am Rev Respir Dis. 1992;146(4):878–883.
17. Burgess JA, Walters EH, Byrnes GB, et al. Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study. Eur Respir J. 2007;29(4):668–675.
18. Watson L, Vonk JM, Lofdahl CG, et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med. 2006;100(4):746–753.
19. Donaldson GC, Seemungal TAR, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128(4):1995–2004.
20. Zaigham S, Wollmer P, Engström G. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up. Eur Respir J. 2016;47(3):742–750.
21. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J. 1994;7(5):954–960.
22. Abramson M, Kutin J, Czarny D, Walters EH. The prevalence of asthma and respiratory symptoms among young adults: is it increasing in Australia? J Asthma. 1996;33(3):189–196.
23. Abramson MJ, Wlodarczyk JH, Hensley MJ, Saunders NA. Evaluation of a new asthma symptoms questionnaire. J Asthma. 1991;28:129–139.
24. Olivieri M, Poli A, Zuccaro P, et al. Tobacco smoke exposure and serum cotinine in a random sample of adults living in Verona, Italy. Arch Environ Health. 2002;57(4):355–359.
25. de Marco R, Marcon A, Jarvis D, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol. 2006;117(6):1249–1256.
26. American Thoracic Society. Standardization of spirometry – 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136(5):1285–1298.
27. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
28. Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(12):1301–1306.
29. Schoenaker DAJM, Jackson CA, Rowlands JV, Mishra GD. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol. 2014;43(5):1542–1562.
30. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404–2411.
31. Triebner K, Johannessen A, Puggini L, et al. Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study. J Allergy Clin Immunol. 2016;137(1):50–57.
32. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? – Report from the obstructive lung disease in Northern Sweden studies. Respir Med. 2003;97(2):115–122.
33. Sorheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6):480–485.
34. Germain D, Durkin S, Scollo M, Wakefield M. The long-term decline of adult tobacco use in Victoria: changes in smoking initiation and quitting over a quarter of a century of tobacco control. Aust N Z J Public Health. 2012;36(1):17–23.
35. Perret JL, Walters EH, Abramson MJ, McDonald CF, Dharmage SC. The independent and combined effects of lifetime smoke exposures and asthma as they relate to COPD. Expert Rev Respir Med. 2014;8(4):503–514.
36. Jensen RL, Teeter JG, England RD, et al. Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. Chest. 2007;132(2):396–402.